Related Experiment Video
Updated: Aug 15, 2025

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
Published on: January 17, 2025
All-Cause and Infection-Related Mortality in Staphylococcus aureus Bacteremia, a Multicenter Prospective Cohort Study
Thomas W van der Vaart1,2, Jan M Prins2, Robin Soetekouw3
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Staphylococcus aureus bacteremia (SAB) causes high mortality, primarily within 30 days. Key risk factors for death include age, comorbidities, septic shock, endocarditis, and persistent bacteremia.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Epidemiology
Background:
- Staphylococcus aureus bacteremia (SAB) presents a significant public health challenge with evolving epidemiology.
- High mortality rates are associated with SAB, yet infection-related mortality requires further quantification.
Purpose of the Study:
- To determine the clinical features of SAB.
- To assess 90-day all-cause and infection-related mortality.
- To identify risk factors for mortality in SAB patients.
Main Methods:
- A multicenter prospective cohort study involving consecutive SAB patients.
- Clinical data collection and adjudication of infection-related mortality by a committee.
- Statistical analysis to determine mortality rates and associated risk factors.
Main Results:
- 490 patients with SAB were analyzed, categorized by acquisition source (community, healthcare, hospital).
- Common SAB-related diagnoses included endocarditis, peripheral intravenous catheter infection, and septic arthritis.
- 90-day all-cause mortality was 33%, with 60% deemed infection-related, predominantly within the first 30 days. Significant mortality risk factors identified were age, Charlson comorbidity index, septic shock, endocarditis, and persistent SAB.
Conclusions:
- Mortality from Staphylococcus aureus infections remains high.
- The majority of infection-related deaths occur within the initial 30 days post-SAB.
- Findings can inform the selection of endpoints in future clinical trials for SAB.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis I: Introduction
Urinary Tract Infection II: Pathophysiology

